Difficulty: Medium
Average Score: 76%
Practice
Which of the following is the primary genetic mutation associated with cystic fibrosis?
Correct answer
A
Rationale
The correct answer is A) CFTR gene mutation. This gene encodes for the cystic fibrosis transmembrane conductance regulator protein, which plays a crucial role in regulating chloride transport across cell membranes. Mutations in the CFTR gene lead to dysfunctional chloride channels, causing the characteristic thick mucus buildup seen in individuals with cystic fibrosis.
Option B) BRCA1 gene mutation is associated with an increased risk of breast and ovarian cancer, not cystic fibrosis. Option C) BRCA2 gene mutation is also linked to a higher susceptibility to breast and ovarian cancer, not cystic fibrosis. Option D) TP53 gene mutation is commonly found in various cancers but is not related to cystic fibrosis.
Educationally, understanding the genetic basis of cystic fibrosis is vital for healthcare professionals, especially nurses preparing for the NCLEX exam. Knowing that the CFTR gene mutation is the primary genetic defect in cystic fibrosis helps in diagnosing and managing patients with this condition. This knowledge informs treatment strategies aimed at addressing the underlying cause of the disease rather than just managing symptoms, leading to better patient outcomes.
Option B) BRCA1 gene mutation is associated with an increased risk of breast and ovarian cancer, not cystic fibrosis. Option C) BRCA2 gene mutation is also linked to a higher susceptibility to breast and ovarian cancer, not cystic fibrosis. Option D) TP53 gene mutation is commonly found in various cancers but is not related to cystic fibrosis.
Educationally, understanding the genetic basis of cystic fibrosis is vital for healthcare professionals, especially nurses preparing for the NCLEX exam. Knowing that the CFTR gene mutation is the primary genetic defect in cystic fibrosis helps in diagnosing and managing patients with this condition. This knowledge informs treatment strategies aimed at addressing the underlying cause of the disease rather than just managing symptoms, leading to better patient outcomes.